<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Official Publication of the National Center for Trauma Research</PublisherName>
				<JournalTitle>Trauma Monthly</JournalTitle>
				<Issn>2251-7464</Issn>
				<Volume>22</Volume>
				<Issue>6</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparing the Effect of Hirudoid on Random Skin Flap Survival in Rats Based on Different Application Times</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">100110</ELocationID>
			
<ELocationID EIdType="doi">10.5812/traumamon.38753</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Babak</FirstName>
					<LastName>Nikoumaram</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Javad</FirstName>
					<LastName>Fatemi</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Shahrzad</FirstName>
					<LastName>Taghavi</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Saberi Isfeedvajani</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Zeinab</FirstName>
					<LastName>Nematzadeh</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Bahareh</FirstName>
					<LastName>Salehi</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Shirin</FirstName>
					<LastName>Araghi</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
		<Abstract>Objectives: The objective of the present study was to compare the use of Hirudoid immediately after surgery with its use 6 hours post-operatively when probable thrombosis was formed but tissue damage was still reversible. Methods: After preparing 3 × 11 cm dorsal flap in all rats, one group of 8 rats received Hirudoid topically immediately after surgery during 9 post-operative days. Another group received it 6 h after surgery during 9 post-operative days. The control group received Vaseline immediately after surgery on a daily basis during 9 post-operative days. Results: The mean area of flap survival in the control group was 8.75 ± 3.32 cm2 (mean ± SD) and it was 12.38±1.93 cm2 and 14.36 ± 3.51 cm2 in Hirudoid immediately after surgery and 6 hours after surgery groups, respectively. Conclusions: It was found that Hirudoid can be effective in improving flap viability; although its effect was not statistically significant when used immediately after surgery (P &gt; 0.05), it significantly increased flap survival when used 6 h after surgery (P = 0.003).</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Skin Random Flap</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ischemia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Flap Necrosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hirudoid</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.traumamon.com/article_100110_c097dd6de04c016a247b324a2c1c1a49.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
